Market revenue in 2023 | USD 1,515.0 million |
Market revenue in 2030 | USD 1,776.2 million |
Growth rate | 2.3% (CAGR from 2023 to 2030) |
Largest segment | Bacterial enteric diseases |
Fastest growing segment | Bacterial Enteric Diseases |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bacterial Enteric Diseases |
Key market players worldwide | Abbott Laboratories, BD, Biomerica Inc, BioMerieux SA, Bio-Rad Laboratories Inc, Danaher Corp, Avacta Group PLC, Diasorin SpA, Meridian Bioscience, Quest Diagnostics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to enteric disease testing market will help companies and investors design strategic landscapes.
Bacterial enteric diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the Europe enteric disease testing market based on bacterial enteric diseases covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe enteric disease testing market , including forecasts for subscribers. This continent databook contains high-level insights into Europe enteric disease testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account